Companies Investors People

Drop to look up

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
Alternatives

For iPhone and iPad

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Dealroom, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Terms of service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Nell

Nell

Nell delivers 100% natural vitamin shots for time-pressed people.

: Acquired by MyHealthChecked
: 2017
: London, GBUnited Kingdom

Nell built an at-home genetic testing platform that turned a customer's DNA sample into personalised diet, exercise, and wellness guidance delivered with support from nutrition experts. The London company sold its DNA tests direct to consumers and served nutritionists, dietitians, and employers running workplace wellbeing programmes.

Its tests differentiated against generic wellness apps and one-size-fits-all supplements by grounding recommendations in each customer's own genetic markers for food intolerance, vitamin deficiency, and exercise response. MyHealthChecked acquired Nell in July 2021 and folded the platform into its MyHealthChecked at-home testing portfolio.

M & A Snapshot

MyHealthChecked
Acquired Nell Jul 2, 2021 for £1.2M

Similar Companies

Gini Health

ginihealth.com

Wellnicity

wellnicity.com

Novogenia

novogenia.com

MyHealthChecked

GenoPalate

genopalate.com

AgoraLV

Paragon Vitamins

livehoned.com

Vivoo

vivoo.io

Fitnescity

fitnescity.com

AssayMe

assayme.cc

Persona Nutrition

Fit Genetics

LifeNome

Nucleus

mynucleus.com

Genetrainer

genetrainer.com

Quinn

quinnbio.com

Plantable

plantable.com

InsideTracker

insidetracker.com

23andMe

23andme.com

Everly Health

everlyhealth.com

Quick Facts

Who are Nell's competitors?

Companies similar to Nell include Gini Health, Wellnicity, Novogenia and MyHealthChecked.

When was Nell founded?

Nell was founded in 2017.

Where is Nell's headquarters located?

Nell's headquarters is located in London, GB.

How much disclosed funding has Nell raised?

As of Jun 28, 2021, Nell has disclosed funding of $20k (USD). Undisclosed round amounts are excluded.

Classification

Industry: Health & Wellness
Technology: Genetic Testing
Geographic Exposure: United Kingdom

Model: Direct To Consumer
Revenue: Direct-to-Consumer
Customer: Consumer

Tags: nutrition
Wellness

Headquarters: London, United Kingdom